Avenue Therapeutics, Inc.
ATXI
$0.28
-$0.03-8.35%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -26.36% | 27.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -25.24% | 31.91% | |||
| Operating Income | 25.24% | -31.91% | |||
| Income Before Tax | 4.27% | -4.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.27% | -4.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | 88.89% | |||
| Net Income | 1.97% | -3.81% | |||
| EBIT | 25.24% | -31.91% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 5.25% | -3.82% | |||
| Normalized Basic EPS | 25.48% | -33.08% | |||
| EPS Diluted | 5.25% | -3.82% | |||
| Normalized Diluted EPS | 25.48% | -33.08% | |||
| Average Basic Shares Outstanding | 3.44% | 0.02% | |||
| Average Diluted Shares Outstanding | 3.44% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||